Concepedia

Kerstin Lühn

KL

Statistics

Publications

41

Citations

3.1K

H-Index

27

Active since

1999

Affiliations

Janssen (Netherlands)(Current)

Janssen (Belgium)

University of Oxford

London School of Hygiene & Tropical Medicine

Mwanza Intervention Trials Unit

Kerstin Lühn is an author at Janssen (Netherlands) specializing in infectious diseases, immunology, and vaccinology.

ORCID

Publications per year

1999–2025

41

Publications

41

The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter

Kerstin Lühn, Martin K. Wild, Matthias Eckhardt et al. · Nature Genetics · 2001 · 339 citations

, , +12

Safety and Immunogenicity of Novel Adenovirus Type 26– and Modified Vaccinia Ankara–Vectored Ebola Vaccines

Iain Milligan, Malick M. Gibani, Richard P. Sewell et al. · JAMA · 2016 · 330 citations

, , +17

Correction of Leukocyte Adhesion Deficiency Type II With Oral Fucose

Thorsten Marquardt, Kerstin Lühn, Geetha Srikrishna et al. · Blood · 1999 · 279 citations

, , +10

Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

Andrew J. Pollard, Odile Launay, Jean‐Daniel Lelièvre et al. · The Lancet Infectious Diseases · 2020 · 170 citations · Full text

, , +14

Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania

Zacchaeus Anywaine, Hilary Whitworth, Pontiano Kaleebu et al. · The Journal of Infectious Diseases · 2019 · 153 citations · Full text

, , +14

1–5 of 41